GeneNovate Investors' Day

The importance of gene and cell therapies as well as tissue therapeutics (advanced medical products) is steadily increasing worldwide. In particular, patients with rare diseases - which affect 4 million people in Germany - and otherwise untreatable cancer patients can benefit from treatment in the long term. Technological advances, such as the expansion of the use of artificial intelligence, are further dynamising the field.

There are currently sixteen gene therapies and one cell therapy approved in Europe (as of December 2024, source vfa). The number of clinical trials worldwide is constantly increasing. Groundbreaking developments are foreseeable for this innovative business field, with sales of up to 27.9 billion euros expected by 2026. The German government has also recognised the potential of these innovative therapies. In a national strategy for gene- and cell-based therapies, specific measures have been defined to improve the framework conditions, e.g. in research and development, regulation or manufacturing practice, in the long term. One initiative is the GeneNovate Entrepreneurship Programme in the field of gene and cell therapies, which, for the second time in 2025, will prepare participants from research and science who are interested in founding a company for the topic of spin-offs from the academic environment and accompany them for six months. Another key pillar of the strategy is the networking of different stakeholders, which enables dialogue across disciplinary, sectoral, regional and national boundaries and thus accelerates translation.

This is where the GeneNovate Investors' Day comes in, because without smart investments and relevant specialist mentoring, there will be no new therapies! GeneNovate^© Investors' Day is a networking event for scientific, translational project teams, international start-ups, investors and experts from science, industry and politics. Discover with us the latest developments in the field of gene and cell therapies and promising investment opportunities. Find out more in exciting panels on key topics such as the special features of the value chain, investment specifics or international best practices. In the heart of Berlin, we create the right atmosphere for personal dialogue!

More information